Background Current cardiovascular disease (CVD) risk prediction models tailored for older adults are inadequate. This study ...

Photon-counting CT (PCCT) represents a transformative advancement in cardiac imaging, addressing key limitations of ...

This May, the World Health Assembly (WHA) will vote on re-establishing a mandate for the WHO to address the health ...

Systolic time intervals and drug plasma concentrations have been measured in a group of patients receiving repeated treatment with nortriptyline. Significant positive correlations between plasma ...

The management of atrial fibrillation (AF) has focused on anticoagulation, rhythm control and ventricular rate control. Recently, a fourth pillar of AF management has been incorporated recognising the ...

Objective To study abnormalities in the resting ECG as independent predictors for all cause, cardiovascular disease (CVD), and coronary heart disease (CHD) mortality in a population based random ...

In recent large-scale cardiovascular outcome trials, two new classes of glucose-lowering medications—sodium glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists ...

Correspondence to Dr Christopher A Miller, BHF Manchester Centre for Heart and Lung Magnetic Resonance Research, The University of Manchester, Manchester M13 9PL, UK; ...

The eye is prone to various forms of afflictions, either as a manifestation of primary ocular disease or part of systemic disease, including the cardiovascular system. A thorough cardiovascular ...

Correspondence to Dr Jill Marie Steiner, Cardiology, University of Washington Medical Center, Seattle, WA 98195, USA; jills8{at}cardiology.washington.edu Cardiovascular disease remains a leading cause ...

Correspondence to Dr Jean Jacques Noubiap, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town 7925, South Africa; noubiapjj{at}yahoo.fr Objectives This scoping ...

Cardiovascular Research Group, Division of Clinical Sciences (Northern General Hospital), University of Sheffield, Sheffield, UK Correspondence to: Dr Julian Gunn, Cardiovascular Research Group, ...